Return
Company Page
Cloverleaf Bio
Founders
Cloverleaf Bio is a Yale University spinout and RNA therapeutics company developing a novel class of engineered transfer RNA (tRNA)-based therapeutics for cancer. Its platform enables direct inhibition of up to 25 enzymes necessary for cancer growth from a single therapeutic molecule, with lead programs targeting hepatocellular carcinoma and colorectal cancer. Backed by major pharma investors, the company is advancing toward early clinical testing.
Company Founded in
Healthtech & Biotech